Sec. 10.52.01.05. Program Design and Operation  


Latest version.
  • A. The CBO or local health department approved to operate an OADPO program:

    (1) Shall provide protocols for the safety and security of OADPO program locations, equipment, and staff in accordance with Regulation .06 of this chapter that:

    (a) Control the dissemination of hypodermic needles and syringes; and

    (b) Allow for a full accounting of the number of hypodermic needles and syringes managed by the program;

    (2) Shall offer participants:

    (a) Overdose prevention education;

    (b) Access to or a referral to obtain naloxone; and

    (c) Harm reduction education;

    (3) Shall ensure that all OADPO program staff have:

    (a) Appropriate levels of expertise in working with individuals who inject drugs;

    (b) Knowledge of harm reduction strategies; and

    (c) Skills in implementing harm reduction strategies;

    (4) Shall ensure that all OADPO program staff receive training approved by the Department to work with injection drug users and to provide referrals to:

    (a) Community services;

    (b) Counseling; and

    (c) Preventative education;

    (5) Shall ensure that all OADPO program staff demonstrate sensitivity to participant differences including:

    (a) Cultural;

    (b) Behavioral; and

    (c) Values;

    (6) Shall ensure that information collected to identify OADPO program participants is kept confidential according to:

    (a) Health-General Article, §24-906(b), Annotated Code of Maryland; and

    (b) 42 CFR Part 2;

    (7) Shall ensure that there is a method of identification and authorization for OADPO program staff members who have access to:

    (a) Hypodermic needles;

    (b) Syringes; and

    (c) OADPO program records;

    (8) Shall develop and provide a protocol for linking participants to:

    (a) Substance abuse treatment services;

    (b) Testing for:

    (i) HIV;

    (ii) Viral hepatitis; and

    (iii) STIs;

    (c) Reproductive health services;

    (d) Wound care; and

    (e) Naloxone;

    (9) Shall disseminate hypodermic needles or syringes and other preventive means for curtailing the spread of HIV and viral hepatitis at no cost to participants, including but not limited to:

    (a) Injection supplies; and

    (b) Safer sex supplies; and

    (10) May not discriminate against participants based on factors including but not limited to:

    (a) Culture;

    (b) Language;

    (c) Ability;

    (d) Socioeconomic status;

    (e) Sexual orientation;

    (f) Gender identity;

    (g) Age;

    (h) Religion;

    (i) Race; and

    (j) Ethnicity.

    B. Identification Card. OADPO program staff shall:

    (1) Give each participant an identification card that includes the participant’s OADPO program identification number;

    (2) Advise participants to carry the identification card with them at all times; and

    (3) If the identification card is lost by a participant, re-issue an identification card to the participant.

    C. The CBO or local health department approved to operate an OADPO program may offer other services to OADPO program participants, including:

    (1) Testing for:

    (a) HIV;

    (b) Viral hepatitis; and

    (c) STIs;

    (2) Wound care;

    (3) Reproductive health services; and

    (4) Substance abuse counseling, treatment, and recovery services.